Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nikolaos A. Triarides"'
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 39:1053-1058
Clostridium difficile infection (CDI) is the most common cause of nosocomial diarrhea in adult patients and is associated with considerable morbidity and mortality. Apart from the standard treatment regimens, tigecycline has shown significant in vitr
Autor:
Georgios D Kalimeris, Nikolaos A. Triarides, Stamatia Chorepsima, Konstantinos S. Kechagias, Matthew E. Falagas
Publikováno v:
Drug Design, Development and Therapy
Non-cystic fibrosis bronchiectasis (NCFB) is a severe chronic illness characterized by irreversible dilation of airways and thickening of bronchial walls, chronic inflammation, repeated infections, and progressive obstruction of the airways. In contr
Autor:
Aigli Kyriakoudi, Margarita Kyriakidou, Matthew E. Falagas, Konstantinos Z. Vardakas, Nikolaos A. Triarides
Publikováno v:
Scientometrics. 116:1559-1564
This article aims to study the effect of the current financial crisis (2010–2017) on biomedical productivity and impact of Greece-affiliated investigators. PubMed, Scopus and Web of Science were searched for articles published in biomedical journal
Publikováno v:
Expert Opinion on Drug Safety. 17:499-508
β-lactams have been consistently associated with the majority of drug-related adverse events. Generally, these are mild under proper dosing and judicious selection.Immediate hypersensitivity reactions are the most feared adverse events encountered a
Publikováno v:
International Journal of Antimicrobial Agents. 47:269-285
The aim of this review was to evaluate the susceptibility of contemporary Gram-positive and Gram-negative bacteria to fosfomycin. PubMed and Scopus databases were systematically searched to identify studies published in print or electronically from J
Autor:
Nikolaos A. Triarides, Matthew E. Falagas, Florentia Athanasaki, Georgios L Voulgaris, Konstantinos Z. Vardakas
Publikováno v:
International journal of antimicrobial agents. 53(1)
Fosfomycin has been used for the treatment of infections due to susceptible and multidrug-resistant (MDR) bacteria. It inhibits bacterial cell wall synthesis through a unique mechanism of action at a step prior to that inhibited by β-lactams. Fosfom
Autor:
Matthew E. Falagas, Anastasios Kapaskelis, Nikolaos S. Roussos, Konstantinos Z. Vardakas, Nikolaos A. Triarides
Publikováno v:
International Journal of Antimicrobial Agents. 45:455-460
Multidrug-resistant (MDR) Acinetobacter baumannii infections have emerged as a serious threat worldwide. As novel agents have yet to be developed, understanding the effectiveness and safety of older antibiotics has become a priority. The purpose of t
Autor:
Nikolaos A. Triarides, Giannoula S. Tansarli, Konstantinos P. Tsiveriotis, Matthew E. Falagas, Konstantinos Z. Vardakas
Publikováno v:
International Journal of Antimicrobial Agents. 44:1-7
Here we review the effectiveness and safety of high-dose tigecycline (200mg daily). A systematic search was performed in PubMed and Scopus databases as well as of abstracts presented at scientific conferences. Eight studies (263 patients; 58% critica
Publikováno v:
International journal of antimicrobial agents. 48(5)
Colistin (polymyxin E) has been widely used since the beginning of the century as a last-option antibiotic for the treatment of patients with multidrug-resistant and extensively-drug resistant bacterial infections. However, colistin dosing is trouble